Literature DB >> 11436108

Tuberculosis among allogeneic bone marrow transplant recipients in India.

B George1, V Mathews, V Srivastava, A Srivastava, M Chandy.   

Abstract

Allogeneic bone marrow transplant recipients have severe impairment of cell-mediated immunity and hence a higher incidence of mycobacterial infections might be expected in regions where tuberculosis is common. We reviewed the case records of 217 patients who underwent allogeneic bone marrow transplantation during the period 1986-1999 at our center in India. Mycobacterial infections were diagnosed in three patients (1.38%). All patients presented with extrapulmonary disease. Two patients had disseminated tuberculosis with one of these being diagnosed on autopsy studies. The third patient had tuberculosis involving the cervical lymph node and dorsal spine. Two patients treated with antituberculous therapy are well. Infection with Mycobacterium tuberculosis is not a common problem in allogeneic bone marrow recipients even in an endemic area, but when it occurs, it is usually disseminated with predominantly extrapulmonary involvement.

Entities:  

Mesh:

Year:  2001        PMID: 11436108     DOI: 10.1038/sj.bmt.1702993

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

1.  Metastatic squamous cell carcinoma urinary bladder coexisting with tuberculosis in pelvic lymph nodes.

Authors:  Vilvapathy Senguttuvan Karthikeyan; Ramanitharan Manikandan; Sajini Elizabeth Jacob; P Puvai Murugan
Journal:  BMJ Case Rep       Date:  2013-12-02

2.  Probability of Finding Marrow Unrelated Donor (MUD) for an Indian patient in a Multi-national Human Leukocyte Antigen (HLA) Registry.

Authors:  Aseem K Tiwari; Himakshi Bhati-Kushwaha; Pooja Kukreja; Vikash C Mishra; Neetu Tyagi; Ashish Sharma; Vimarsh Raina
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-11       Impact factor: 0.900

3.  Analysis of Clinical Profile and Outcome of Tuberculosis in Patients with Acute Leukemia.

Authors:  Arihant Jain; Gaurav Prakash; Charanpreet Singh; Deepesh Lad; Alka Khadwal; Vikas Suri; Pankaj Malhotra; Savita Kumari; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-12       Impact factor: 0.900

4.  Tuberculosis in hematopoietic stem cell transplant recipients in Korea.

Authors:  Jeeyun Lee; Mark H Lee; Won Seog Kim; Kihyun Kim; Se Hoon Park; Se-Hoon Lee; Kyung-Eun Lee; Jinny Park; Joon Oh Park; Chul Won Jung; Young-Hyuck Im; Won Ki Kang; Keunchil Park
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 5.  Tuberculosis in patients with haematological malignancies.

Authors:  Luis Anibarro; Alberto Pena
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

Review 6.  Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients.

Authors:  Melanie Dubois; Avika Dixit; Gabriella Lamb
Journal:  Glob Pediatr Health       Date:  2021-01-15

Review 7.  Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma Marzouq Al-Jasser; Khalid Alsaleh
Journal:  Front Oncol       Date:  2014-08-26       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.